Artificial intelligence for dementia research methods optimization
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Artificial intelligence (AI) and machine learning (ML) approaches are increasingly being used in dementia research. However, several methodological challenges exist that may limit the insights we can obtain from high‐dimensional data and our ability to translate these findings into improved patient outcomes. To improve reproducibility and replicability, researchers should make their well‐documented code and modeling pipelines openly available. Data should also be shared where appropriate. To enhance the acceptability of models and AI‐enabled systems to users, researchers should prioritize interpretable methods that provide insights into how decisions are generated. Models should be developed using multiple, diverse datasets to improve robustness, generalizability, and reduce potentially harmful bias. To improve clarity and reproducibility, researchers should adhere to reporting guidelines that are co‐produced with multiple stakeholders. If these methodological challenges are overcome, AI and ML hold enormous promise for changing the landscape of dementia research and care. Highlights: Machine learning (ML) can improve diagnosis, prevention, and management of dementia. Inadequate reporting of ML procedures affects reproduction/replication of results. ML models built on unrepresentative datasets do not generalize to new datasets. Obligatory metrics for certain model structures and use cases have not been defined. Interpretability and trust in ML predictions are barriers to clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
Rajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579
Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author)
Breiman, L. (2001) · Statistical Science · doi:10.1214/ss/1009213726 · Cited by 4,340
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
A survey on semi-supervised learning
van Engelen, J. E., & Hoos, H. H. (2020) · Machine Learning · doi:10.1007/s10994-019-05855-6 · Cited by 2,666
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Automatic classification of MR scans in Alzheimer’s disease.
Kloppel, S., Stonnington, C. M., Chu, C., Draganski, B., Scahill, R. I., Rohrer, J. D., Fox, N. C., Jack, C. R., Ashburner, J., & Frackowiak, R. S. J. (2008) · Brain · doi:10.1093/brain/awm319 · Cited by 1,170
Grubman, A., Chew, G., Ouyang, J. F., Sun, G., Choo, X. Y., McLean, C., Simmons, R. K., Buckberry, S., Vargas-Landin, D. B., Poppe, D., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0539-4 · Cited by 956
The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set
Beekly, D. L., Ramos, E. M., Lee, W. W., Deitrich, W. D., Jacka, M. E., Wu, J., Hubbard, J. L., Koepsell, T. D., Morris, J. C., & Kukull, W. A. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318142774e · Cited by 907
Park, S. H., & Han, K. (2018) · Radiology · doi:10.1148/radiol.2017171920 · Cited by 894
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Initiative, T. A. D. N., Vogel, J. W., Young, A. L., Oxtoby, N. P., Smith, R., Ossenkoppele, R., Strandberg, O. T., La Joie, R., Aksman, L. M., Grothe, M. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01309-6 · Cited by 741 · cited 1×
“62 One such model, the event-based model, 59 builds upon the hypothetical cascade model to obtain a sequence of events that describe one or more subtypes of disease progression.”
BackgroundArtificial intelligence for clinical trial design
Harrer, S., Shah, P., Antony, B., & Hu, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.005 · Cited by 672 · cited 2×
“Ultimately, this can lead to the offering of new treatments to the right population at a faster pace [112,113].”
BackgroundscGen predicts single-cell perturbation responses
Lotfollahi, M., Wolf, F. A., & Theis, F. J. (2019) · Nature Methods · doi:10.1038/s41592-019-0494-8 · Cited by 661
Improving the accuracy of medical diagnosis with causal machine learning
Richens, J. G., Lee, C. M., & Johri, S. (2020) · Nature Communications · doi:10.1038/s41467-020-17419-7 · Cited by 598
Young, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05892-0 · Cited by 596
Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24647 · Cited by 542 · cited 1×
“39,40 These studies span varied modalities including clinical and phenotypic information, 41 molecular measure-mentsinperipheraltissues, 42 neuroimaging, 43 aswellasmultipletypes of omic analyses in post mortem brains.”
BackgroundDementia: timely diagnosis and early intervention
Robinson, L., Tang, E., & Taylor, J.-P. (2015) · BMJ · doi:10.1136/bmj.h3029 · Cited by 503 · cited 1×
“The timely detection of dementia is crucial in enabling effective disease management and providing optimal health care [2].”
BackgroundPlasma tau in Alzheimer disease
Mattsson, N., Zetterberg, H., Janelidze, S., Insel, P. S., Andreasson, U., Stomrud, E., Palmqvist, S., Baker, D., Tan Hehir, C. A., Jeromin, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003246 · Cited by 502 · cited 1×
“These studies span across varied modalities including clinical and phenotypic information [34], molecular measurements in peripheral tissues [35], neuroimaging [36], as well as multiple types of omic”
BackgroundQiu, S., Joshi, P. S., Miller, M. I., Xue, C., Zhou, X., Karjadi, C., Chang, G. H., Joshi, A. S., Dwyer, B., Zhu, S., et al. (2020) · Brain · doi:10.1093/brain/awaa137 · Cited by 472
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Predicting alzheimer’s disease progression using multi-modal deep learning approach
Lee, G., Nho, K., Kang, B., Sohn, K.-A., Kim, D., Initiative, F. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37769-z · Cited by 406
El-Sappagh, S., Alonso, J. M., Islam, S. M. R., Sultan, A. M., & Kwak, K. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82098-3 · Cited by 363 · cited 1×
“26 models with low interpretability; trust can be improved with transparent, explainable approaches [146], and reporting an algorithm’s confidence in its decision [147].”
BackgroundA data-driven model of biomarker changes in sporadic Alzheimer’s disease
Young, A. L., Oxtoby, N. P., Daga, P., Cash, D. M., Fox, N. C., Ourselin, S., Schott, J. M., & Alexander, D. C. (2014) · Brain · doi:10.1093/brain/awu176 · Cited by 308
Grueso, S., & Viejo-Sobera, R. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00900-w · Cited by 303
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
Rodriguez, S., Hug, C., Todorov, P., Moret, N., Boswell, S. A., Evans, K., Zhou, G., Johnson, N. T., Hyman, B. T., Sorger, P. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21330-0 · Cited by 299
Spooner, A., Chen, E., Sowmya, A., Sachdev, P., Kochan, N. A., Trollor, J., & Brodaty, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-77220-w · Cited by 284
Randomized Clinical Trials of Machine Learning Interventions in Health Care: A Systematic Review
Plana, D., Shung, D. L., Grimshaw, A. A., Saraf, A., Sung, J. J. Y., & Kann, B. H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.33946 · Cited by 236 · cited 1×
“Clinical trials for ML interventions in dementia (similar to those designed for cancer research [148]) could evaluate the clinical utility of ML models given their inherent opacity and ‘black-box’ nature, as well as address the challenges related to generalizability and interpretability of ML models.”
BackgroundQuang, D., & Xie, X. (2019) · Methods · doi:10.1016/j.ymeth.2019.03.020 · Cited by 204
Predicting dementia from spontaneous speech using large language models
Agbavor, F., & Liang, H. (2022) · PLOS Digital Health · doi:10.1371/journal.pdig.0000168 · Cited by 147 · cited 2×
“99 Numerous studies have suggested that analysis of acous-ticfeaturesextractedfromspeechaudioandlinguisticfeaturesderived from written texts or speech transcripts may lead to the discovery of novel, non-invasive biomarkers of cognitive impairment given that subtle changes in language can be…”
BackgroundNeuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects
Ahmed, M. R., Zhang, Y., Feng, Z., Lo, B., Inan, O. T., & Liao, H. (2019) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2018.2886237 · Cited by 142
Ansart, M., Epelbaum, S., Bassignana, G., Bône, A., Bottani, S., Cattai, T., Couronné, R., Faouzi, J., Koval, I., Louis, M., et al. (2021) · Medical Image Analysis · doi:10.1016/j.media.2020.101848 · Cited by 116
Imaging plus X: multimodal models of neurodegenerative disease
Oxtoby, N. P., & Alexander, D. C. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000460 · Cited by 105
Li, H., & Fan, Y. (2019) · 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019) · doi:10.1109/isbi.2019.8759397 · Cited by 83 · cited 1×
“Most DL applications in dementia research have involved convolutional neural networks (CNNs) [68,69], autoencoders [70,71], and recurrent neural networks (RNNs) [72,73].”
BackgroundBenchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
De Velasco Oriol, J., Vallejo, E. E., Estrada, K., Taméz Peña, J. G., & Disease Neuroimaging Initiative, T. A. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3158-x · Cited by 71
The Next Generation of Medical Decision Support: A Roadmap Toward Transparent Expert Companions
Bruckert, S., Finzel, B., & Schmid, U. (2020) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2020.507973 · Cited by 66 · cited 1×
“147,148 The interpretability of an algorithm can be divided into two classes: globalinterpretabilityandlocalinterpretability.”
MethodAn automatic Alzheimer’s disease classifier based on spontaneous spoken English
Bertini, F., Allevi, D., Lutero, G., Calzà, L., & Montesi, D. (2022) · Computer Speech & Language · doi:10.1016/j.csl.2021.101298 · Cited by 66
Bucholc, M., McClean, P. L., Bauermeister, S., Todd, S., Ding, X., Ye, Q., Wang, D., Huang, W., & Maguire, L. P. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12122 · Cited by 64
Self-citationKauppi, K., Fan, C. C., McEvoy, L. K., Holland, D., Tan, C. H., Chen, C.-H., Andreassen, O. A., Desikan, R. S., Dale, A. M., & Initiative, T. A. D. N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00260 · Cited by 60
Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells
Navarro, E., Udine, E., Lopes, K. D. P., Parks, M., Riboldi, G., Schilder, B. M., Humphrey, J., Snijders, G. J. L., Vialle, R. A., Zhuang, M., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00110-x · Cited by 57
Self-citationBurgos, N., & Colliot, O. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000838 · Cited by 53
Artificial intelligence for dementia drug discovery and trials optimization
Doherty, T., Yao, Z., Khleifat, A. A. L., Tantiangco, H., Tamburin, S., Albertyn, C., Thakur, L., Llewellyn, D. J., Oxtoby, N. P., Lourida, I., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13428 · Cited by 48
Self-citationArtificial intelligence for dementia prevention
Newby, D., Orgeta, V., Marshall, C. R., Lourida, I., Albertyn, C. P., Tamburin, S., Raymont, V., Veldsman, M., Koychev, I., Bauermeister, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13463 · Cited by 42
Self-citationDeep belief network-based approach for detecting Alzheimer's disease using the multi-omics data
Mahendran, N., & Vincent P M, D. R. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.021 · Cited by 31
Artificial intelligence for dementia genetics and omics
Bettencourt, C., Skene, N., Bandres‐Ciga, S., Anderson, E., Winchester, L. M., Foote, I. F., Schwartzentruber, J., Botia, J. A., Nalls, M., Singleton, A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13427 · Cited by 30
Self-citationWang, Y., Gu, X., Hou, W., Zhao, M., Sun, L., & Guo, C. (2023) · Brain Sciences · doi:10.3390/brainsci13020306 · Cited by 17 · cited 1×
“87 There are several key challenges that limit the translation of DL methods into clinical practice.”
Background
Cited by
Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: a systematic review
Borchert, R. J., Azevedo, T., Badhwar, A., Bernal, J., Betts, M., Bruffaerts, R., Burkhart, M. C., Dewachter, I., Gellersen, H. M., Low, A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13412 · Cited by 125
Self-citationArtificial intelligence for dementia prevention
Newby, D., Orgeta, V., Marshall, C. R., Lourida, I., Albertyn, C. P., Tamburin, S., Raymont, V., Veldsman, M., Koychev, I., Bauermeister, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13463 · Cited by 42
“39 43 In contrast, ML techniques do not make a priori assumptions about the distribution from which the modeling sample is drawn, and hence they can be effective even in the presence of complex non-linear relationships and when the data are collected without a controlled experimental design.”
MethodSelf-citationRichter-Laskowska, M., Sobotnicka, E., & Bednorz, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-90460-y · Cited by 16
“In future research, data preprocessing will remain a challenge 8 , particularly in studies using EMRs 20 , and initial feature selection will be crucial to develop more precise ML models, as indicated by other studies 9,19,33 .”
Influential
Metadata
- Authors
- Bucholc, M., James, C., Khleifat, A. A., Badhwar, A., Clarke, N., Dehsarvi, A., Madan, C. R., Marzi, S. J., Shand, C., Schilder, B. M., Tamburin, S., Tantiangco, H. M., The Deep Dementia Phenotyping (DEMON) Network, Lourida, I., Llewellyn, D. J., & Ranson, J. M.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2023-08-28
- Volume
- 19
- Issue
- 12
- Pages
- 5934-5951
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W4324018738
- Cited by
- 40
- References
- 45
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.